Outpatient oxaliplatin desensitizations A process improvement evaluation

被引：6
作者：
Barmettler, Sara [1 ]
Wolfson, Anna [1 ]
Yang, Nancy [1 ]
Fu, Xiaoqing [1 ,2 ]
Blumenthal, Kimberly [1 ,2 ,3 ]
Banerji, Aleena [1 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Mongan Inst, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Edward P Lawrence Ctr Qual & Safety, Boston, MA 02114 USA
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2019年 / 123卷 / 06期
基金：
美国国家卫生研究院;
关键词：
RISK-STRATIFICATION; HYPERSENSITIVITY; PROTOCOL; CHEMOTHERAPY; CARBOPLATIN;
D O I：
10.1016/j.anai.2019.08.021
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：605 / +
页数：4
相关论文
共 10 条
  • [1] [Anonymous], 2009, COMM TERM CRIT ADV E
  • [2] Advanced (>second) line chemotherapy in the treatment of patients with recurrent epithelial ovarian cancer
    Bruchim, Ilan
    Jarchowsky-Dolberg, Osnat
    Fishman, Ami
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 166 (01) : 94 - 98
  • [3] Green R, 2006, ONCOL NURS FORUM, V33, P437
  • [4] Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement
    Kowalski, Marek L.
    Ansotegui, Ignacio
    Aberer, Werner
    Al-Ahmad, Mona
    Akdis, Mubeccel
    Ballmer-Weber, Barbara K.
    Beyer, Kirsten
    Blanca, Miguel
    Brown, Simon
    Bunnag, Chaweewan
    Capriles Hulett, Arnaldo
    Castells, Mariana
    Chng, Hiok Hee
    De Blay, Frederic
    Ebisawa, Motohiro
    Fineman, Stanley
    Golden, David B. K.
    Haahtela, Tari
    Kaliner, Michael
    Katelaris, Connie
    Lee, Bee Wah
    Makowska, Joanna
    Muller, Ulrich
    Mullol, Joaquim
    Oppenheimer, John
    Park, Hae-Sim
    Parkerson, James
    Passalacqua, Giovanni
    Pawankar, Ruby
    Renz, Harald
    Rueff, Franziska
    Sanchez-Borges, Mario
    Sastre, Joaquin
    Scadding, Glenis
    Sicherer, Scott
    Tantilipikorn, Pongsakorn
    Tracy, James
    van Kempen, Vera
    Bohle, Barbara
    Canonica, G. Walter
    Caraballo, Luis
    Gomez, Maximiliano
    Ito, Komei
    Jensen-Jarolim, Erika
    Larche, Mark
    Melioli, Giovanni
    Poulsen, Lars K.
    Valenta, Rudolf
    Zuberbier, Torsten
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2016, 9 : 1 - 42
  • [5] Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: Standard protocol effective in 57 patients for 255 courses
    Lee, CW
    Matulonis, UA
    Castells, MC
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 99 (02) : 393 - 399
  • [6] A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions
    Patil, Sarita U.
    Long, Aidan A.
    Ling, Morris
    Wilson, Michael T.
    Hesterberg, Paul
    Wong, Johnson T.
    Banerji, Aleena
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : 443 - 447
  • [7] Developing an Interdisciplinary, Team-Based Quality Improvement Leadership Training Program for Clinicians: The Partners Clinical Process Improvement Leadership Program
    Rao, Sandhya K.
    Carballo, Victoria
    Cummings, Brian M.
    Millham, Frederick
    Jacobson, Joseph O.
    [J]. AMERICAN JOURNAL OF MEDICAL QUALITY, 2017, 32 (03) : 271 - 277
  • [8] Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy
    Wang, Alberta L.
    Patil, Sarita U.
    Long, Aidan A.
    Banerji, Aleena
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : 422 - 428
  • [9] Wheeler D., UNDERSTANDING STAT P
  • [10] Oxaliplatin Hypersensitivity: Evaluation, Implications of Skin Testing, and Desensitization
    Wong, Johnson T.
    Ling, Morris
    Patil, Sarita
    Banerji, Aleena
    Long, Aidan
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2014, 2 (01) : 40 - 45
1